Advertisement

Related Videos

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Opening Session Panel Discussion

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Amit Sanyal, MD: A Clinician’s Perspective

Advertisement

Advertisement




Apr
20
Today In Oncology
Alectinib Approved as Adjuvant Treatment for ALK-Positive Non–Small Cell Lung Cancer
Professional Societies Introduce New Evidence-Based Guidelines on Testing Immunotherapy Biomarkers in NSCLC
Accelerated Aging May Be a Risk Factor for Early-Onset Cancers in Younger Generations
Novel MDM2 Inhibitor Shows Activity in Salivary Gland Cancers
Novel SPECT/CT Imaging Technique Under Study in Prostate Cancer
View More 
Advertisement
© 2024 HSP News Service, L.L.C.
Designed by Harborside